Targeting of HBP1/TIMP3 axis as a novel strategy against breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting of HBP1/TIMP3 axis as a novel strategy against breast cancer

Published:2023-08 Issue: Volume:194 Page:106846
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Zhou Yue,Zhang Tongjia,Wang Shujie,Yang Ruixiang,Jiao Zitao,Lu Kejia,Li Hui,Jiang Wei,Zhang Xiaowei

Funder

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference50 articles.

1. Awareness and current knowledge of breast cancer;Akram;Biol. Res,2017

2. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

3. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast conserving therapy;Nguyen;J. Clin. Oncol.,2008

4. Clonal heterogeneity and tumor evolution: past, present, and the future;McGranahan;Cell,2017

5. The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways;Bollaert;Cell Mol. Life Sci.,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fe3O4 coated stent prevent artery neointimal hyperplasia by inhibiting vascular smooth muscle cell proliferation;Materials Today Bio;2024-08

2. Integrated systematic functional screen and fine-mapping decipher the role and genetic regulation of RPS19 in colorectal cancer development;Archives of Toxicology;2024-07-16

3. CSF-1R: A promising therapeutic target for various diseases;Pharmacological Research;2024-06

4. Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology;International Journal of Molecular Sciences;2024-03-10

5. Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes;Biomedical Engineering and Computational Biology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3